Mochida Pharmaceutical Co., Ltd. (TYO:4534)
Japan · Delayed Price · Currency is JPY 3,310.00
+45.00 (1.38%)
Aug 25, 2026, 3:30 PM JST
Mochida Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 11,171 | 8,052 | 6,160 | 9,044 | 14,591 |
Depreciation & Amortization | 2,979 | 2,940 | 2,808 | 2,672 | 2,689 |
Loss (Gain) From Sale of Assets | 1 | 14 | -22 | 53 | 112 |
Loss (Gain) From Sale of Investments | 72 | - | -100 | - | -526 |
Loss (Gain) on Equity Investments | -793 | 618 | 168 | - | - |
Other Operating Activities | -2,255 | -951 | -1,366 | -4,172 | -5,709 |
Change in Accounts Receivable | -4,859 | 3,220 | -7,032 | 3,869 | -2,486 |
Change in Inventory | -2,825 | -3,016 | -5,873 | -1,277 | -521 |
Change in Accounts Payable | 2,116 | -3,522 | 2,225 | -1,941 | 2,176 |
Change in Other Net Operating Assets | -12,957 | 1,999 | -4,448 | -951 | -2,867 |
Operating Cash Flow | -7,350 | 9,354 | -7,480 | 7,297 | 7,459 |
Operating Cash Flow Growth | - | - | - | -2.17% | -18.91% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -2,695 | -2,160 | -2,296 | -2,166 | -2,988 |
Sale of Property, Plant & Equipment | - | 2 | 56 | - | - |
Investment in Securities | -14,160 | 19,500 | 2,301 | -1,100 | 1,098 |
Other Investing Activities | 7 | 13 | 13 | 317 | -117 |
Investing Cash Flow | -16,848 | 17,355 | 74 | -2,949 | -2,007 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 10,000 | - | - | - | - |
Net Debt Issued (Repaid) | 10,000 | - | - | - | - |
Repurchase of Common Stock | -2 | -3 | -3,492 | -3,512 | -2,511 |
Common Dividends Paid | -2,835 | -2,835 | -2,887 | -3,372 | -3,445 |
Other Financing Activities | -130 | -27 | -14 | - | - |
Financing Cash Flow | 7,033 | -2,865 | -6,393 | -6,884 | -5,956 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 73 | 16 | 79 | 32 | 31 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 1 |
Net Cash Flow | -17,092 | 23,860 | -13,720 | -2,504 | -472 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -10,045 | 7,194 | -9,776 | 5,131 | 4,471 |
Free Cash Flow Growth | - | - | - | 14.76% | -38.44% |
Free Cash Flow Margin | -8.59% | 6.84% | -9.50% | 4.97% | 4.06% |
Free Cash Flow Per Share | -283.36 | 202.93 | -272.59 | 138.08 | 117.34 |
Levered Free Cash Flow | -10,032 | 6,041 | -10,050 | 5,890 | 5,615 |
Unlevered Free Cash Flow | -9,987 | 6,042 | -10,049 | 5,890 | 5,615 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 87 | 18 | 37 | 35 | 36 |
Cash Income Tax Paid | 2,353 | 948 | 1,368 | 3,224 | 3,616 |
Change in Working Capital | -18,525 | -1,319 | -15,128 | -300 | -3,698 |